|
Sep 28
|
Clearmind Medicine to Present at the LD Micro Main Event XVI Investor Conference on October 4th
|
|
Aug 1
|
Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio
|
|
Aug 1
|
SciSparc and Clearmind Collaboration Continues to Increase its Patent Portfolio in the Field of Movement Abnormalities in the U.S.
|
|
Jul 17
|
Clearmind Medicine Announces Share-Based Payment for the Company's Consultants
|